▲ Peaking
Business
Merck CEO tells CNBC he expects breakthrough cancer vaccine will become faster to make
Merck CEO Rob Davis tells CNBC that manufacturing timelines for a breakthrough cancer vaccine will shorten.
1 trends tracked about this subject — the full history, oldest to newest below.
Merck CEO Rob Davis tells CNBC that manufacturing timelines for a breakthrough cancer vaccine will shorten.